Dew, applying the U.S. Logic, a patient in Europe could equally move to 8w Gilead's regimen at lower cost. Not sure why this would be any different in Europe vs US. T.I.A P.S: congratulations on finding another winner in Enanta and thanks for sharing all the DD with board members.